Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.19.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses:        
Research and development $ 4,205,200 $ 5,261,100 $ 8,519,100 $ 8,004,800
General and administrative 1,146,100 2,171,000 3,056,200 3,637,300
Total operating expenses 5,351,300 7,432,100 11,575,300 11,642,100
Loss from operations (5,351,300) (7,432,100) (11,575,300) (11,642,100)
Other income (expenses), net:        
Interest income (expense), net 15,400 (2,900) 31,900 (5,000)
Loss before income taxes (5,335,900) (7,435,000) (11,543,400) (11,647,100)
Income taxes 0 0 (2,400) (2,400)
Net loss and comprehensive loss (5,335,900) (7,435,000) (11,545,800) (11,649,500)
Accrued dividends on Series B Preferred stock (313,800) (283,600) (616,300) (557,100)
Net loss attributable to common stockholders $ (5,649,700) $ (7,718,600) $ (12,162,100) $ (12,206,600)
Basic and diluted net loss attributable to common stockholders per common share $ (0.13) $ (0.30) $ (0.29) $ (0.50)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 42,622,965 25,815,245 42,622,965 24,267,816